Previous close | 3.0900 |
Open | 3.0093 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.8600 - 3.0093 |
52-week range | 2.4000 - 11.7700 |
Volume | |
Avg. volume | 24,884 |
Market cap | 3.418M |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | -12.9700 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 20.00 |
BERWYN, Pa., March 26, 2024--Virpax Reports 2023 Year-End Results
BERWYN, Pa., February 27, 2024--Virpax Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
BERWYN, Pa., February 27, 2024--Virpax Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.